Key points
- Genetics is the study of genes and how traits or conditions are passed from one generation to the next.
- Genomics is the study of all of a person's genes, the genome, including how they interact with each other and with the environment.
- Genetics explains diseases caused mainly by a single gene, such as cystic fibrosis. Genomics is needed for complex diseases influenced by many genes and the environment.
- All humans are about 99.9% identical in their DNA. The remaining 0.1% holds important clues about the causes of disease.
- Drug discovery uses genetics to understand single-gene diseases and genomics to find targets across whole populations.
The words genetics and genomics are often used interchangeably, but they describe different scales of study. The difference matters for understanding how diseases arise and how new drugs are found.
The short answer
The National Human Genome Research Institute (NHGRI) draws the distinction this way:
- Genetics refers to the study of genes and the way certain traits or conditions are passed down from one generation to another.
- Genomics describes the study of all of a person's genes, the genome, including how those genes interact with each other and with the person's environment.
Genetics usually looks closely at one gene or a few genes. Genomics looks at the whole picture at once.
Side by side
| Genetics | Genomics | |
|---|---|---|
| Scope | Individual genes | The entire genome |
| Central question | How is this trait or condition inherited? | How do all the genes, and the environment, together influence health? |
| Typical diseases studied | Single-gene (monogenic) conditions | Complex conditions involving many genes |
| Typical methods | Family studies, single-gene tests | Genome-wide sequencing and association studies across large populations |
| Origins | Gregor Mendel's inheritance experiments in the 1800s | The Human Genome Project (1990–2003) and later large-scale sequencing |
Genetics: one gene at a time
Classical genetics follows how traits pass through families. Many serious conditions are caused mainly by changes in a single gene. These include cystic fibrosis, sickle cell disease, and Huntington's disease.
Cystic fibrosis is a classic example. In 1989, researchers reported in Science that they had identified the gene responsible, now called CFTR, on chromosome 7. Knowing the gene made it possible to test for the condition, understand what goes wrong in the cell, and eventually develop drugs that improve the function of the faulty CFTR protein in patients with specific variants.
Genomics: the whole genome at once
Most common diseases, such as heart disease, type 2 diabetes, asthma, and most cancers, are not caused by one gene. Many genetic variants each contribute a small amount of risk, and environment and lifestyle add more. Studying them requires looking across the whole genome in very large numbers of people.
Genome-wide association studies (GWAS) do this by testing millions of variants across the genome for links to a disease or trait. The NHGRI-EBI GWAS Catalog collects the published results. NHGRI notes that all humans are about 99.9% identical in their genetic makeup, and that the remaining 0.1% holds important clues about the causes of diseases.
How each helps drug discovery
| Contribution | Genetics | Genomics |
|---|---|---|
| Finding a target | Identifies the single faulty gene behind a rare disease | Finds genes and pathways linked to common diseases across populations |
| Validating a target | Shows what happens when a gene is broken in families | Shows how variants in a gene affect disease risk in hundreds of thousands of people |
| Choosing patients | Identifies carriers of a specific variant | Uses tumor or patient genome profiles to select treatment |
| Predicting side effects | Detects variants that cause rare drug reactions | Shows where a target gene is active across the body |
The two approaches converge in one of the strongest findings in drug development. Drug programs whose targets are supported by human genetic evidence, from single-gene disorders and genome-wide studies alike, have been about 2.6 times more likely to succeed in clinical development, according to a 2024 analysis in Nature. See What Is Genomics?
Why the distinction is blurring
The line between genetics and genomics is fading in practice. A patient with a suspected single-gene disorder may now have their whole genome sequenced to find the cause, which is a genomic method used to answer a genetic question. Meanwhile, genome-wide studies regularly uncover individual genes with large effects. Most researchers now move between both scales as needed.
Related terms
- Gene: a unit of DNA that provides instructions for making a protein or another functional molecule. See What Are Genes and How Do They Work?
- Genome: all of an organism's DNA.
- Variant (mutation): a difference in the DNA sequence. See What Are Genetic Mutations?
- Pharmacogenomics: how genetic differences affect responses to drugs.
Sources
- National Human Genome Research Institute. Genetics vs. Genomics Fact Sheet.Regulator
- National Human Genome Research Institute. A Brief Guide to Genomics.Regulator
- Riordan JR, et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science. 1989;245(4922):1066–1073.Peer-reviewed
- NHGRI-EBI GWAS Catalog.Registry
- Minikel EV, Painter JL, Dong CC, Nelson MR. Refining the impact of genetic evidence on clinical success. Nature. 2024;629:624–629.Peer-reviewed
This article is for education. It is not medical advice and not investment advice. Figures are drawn from the sources above and describe historical averages, not the prospects of any particular drug. See our editorial standards and disclaimer.